In Vitro Inhalation Testing: Revolutionizing Inhalation Product Safety
January 24, 2024
Discover how the expoCube was used in a study to understand the possible adverse acute inhalation effects of aerosols on consumer safety.
The 2024 Safety Pharmacology Society took place in San Diego, California from September 22nd to the 25th at the Town and Country Resort. emka Technologies Booth 207 !
In this presentation, David Brunet, President of emka Technologies, highlighted the latest advancements in inhaled drug development, particularly focusing on unmet needs in respiratory diseases. While the pharmaceutical industry often concentrates on oncology and neurological diseases, he emphasized the critical need for innovation in treating respiratory conditions like chronic obstructive pulmonary disease (COPD), asthma, idiopathic pulmonary fibrosis (IPF), and cystic fibrosis (CF).
Discover how the expoCube was used in a study to understand the possible adverse acute inhalation effects of aerosols on consumer safety.
SCIREQ hosted a panel discussion on Bridging the Gap Across Models: Integrating In Vivo and In Vitro Inhalation Toxicity Assessments on March 13th at SOT in Utah.
SCIREQ Preclinical Solutions offers a comprehensive suite of tools and equipment that can be employed for inhaled drug delivery research.